IVAC MUTANOME: A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma

Matthias Miller, Uğur Şahin, Evelyna Derhovanessian, B-P Kloke, Petra Simon, Valesca Bukur, Clemens Albrecht, Anna Paruzynski, Martin Löwer, Andreas N. Kuhn,

Annals of Oncology · 2017 · 15 citations · 0 references

DOIFull text

Open access

Concepts